SPRIM PRO and ObvioHealth, both part of the SPRIM Group, have announced an expansion of their partnership to provide a fully integrated trial solution to sponsors. This collaboration combines ...

SINGAPORE and NEW YORK, March 10, 2025 /CNW/ -- SPRIM Global Investments ("SGI"), a global investment firm specializing in clinical-stage life sciences and pharma services based in Singapore, and One ...

NEW YORK, July 15, 2025 /PRNewswire/ -- SPRIM PRO and ObvioHealth, sister companies within the SPRIM Group, have expanded their collaboration to deliver a fully integrated clinical trial solution that ...

Biotech Acquisition Company, a blank check company formed by CRO and venture investor SPRIM targeting the biotech industry, filed on Thursday with the SEC for an initial public offering. The New York, ...

MELBOURNE, AUSTRALIA / ACCESSWIRE / January 16, 2024 / Prota Therapeutics Pty Ltd (Prota), an Australian biotechnology company focused on the development of novel oral immunotherapy treatments that ...

PARIS--(BUSINESS WIRE)--Regulatory News: Tikehau Capital (Paris:TKO), the pan-European alternative asset management and investment company, and SPRIM Ventures, a world-class global medical and ...

Add Yahoo as a preferred source to see more of our stories on Google. European investment firm Tikehau Capital has partnered with Sprim Ventures, the venture arm of Singapore-based healthcare ...

Spexis receives second extension for the publication of its 2023 annual report until July 31, 2024, releasing its unaudited financial statements and providing an update on its dispute with SPRIM.

The strategic partnership will fuel the expansion of SGI's specialized financing platform, TrialCap, a pioneering financing solution designed to support clinical trials from Phase 1 through Phase 3.